Researchers in Prof. Emmanuel Mignot's laboratory developed a mouse monoclonal antibody to the N-terminal end of the hypocretin-1 protein (Hcrt-1, also known as orexin-A).
Researchers in Dr. Michael Cleary's laboratory at Stanford University have developed a highly specific monoclonal antibody for AF5, a proto-oncoprotein associated with pediatric and adult acute leukemia.
Researchers in Prof. Stephen Quake's laboratory have developed a method to measure the entire fetal genome noninvasively using materials from maternal blood.
This invention enables the high-sensitivity, high-resolution stacking, separation, and fluorescence-based detection of non-fluorescent analytes in any electrophoresis platform.
A team of Stanford researchers has developed an in vitro system for the detection and quantification of basophils. The technology can be used to identify and monitor patients with immune system disorders - such as anaphylaxis, myeloproliferative disorders, or infections.
Stanford researchers have developed a method that not only detects B- and T-cell cancers but also is sufficiently sensitive to detect residual cancer in patients.
Researchers in Dr. Michael Cleary's laboratory at Stanford University have developed a highly specific monoclonal antibody for AF4, a proto-oncoprotein associated with pediatric and adult leukemia.
Researchers in Dr. Michael Cleary's laboratory at Stanford University have developed a highly specific monoclonal antibody for ENL, a proto-oncoprotein associated with pediatric and adult leukemia.
Stanford scientists in Dr. Liqun Luo's laboratory have developed a patented method for site-directed somatic cell recombination and concurrent labeling of "knock in" cells.
Monoclonal antibody that recognizes MLL, an oncoprotein that is mutated in a broad subset of pediatric and adult leukemias. MLL protein displays histone methyltransferase activity.
Rat monoclonal antibody isotype IgG2a (clone #153) recognizes the HA peptide sequence [YPYDVPDYA] derived from the influenza hemagglutinin protein. The HA peptide can be added to unrelated proteins through recombinant techniques.
Hybridoma cells for the production of monoclonal antibodies against C-terminal fragment of fly patched were made by fusion of spleen cells from an immune mouse and sp2/0 myeloma cells.